Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 8/20 | 0.43 |
| ▸ | HTR1A known ✓ | P08908 | 7/20 | 0.43 |
| ▸ | DRD2 known ✓ | P14416 | 4/20 | 0.42 |
| ▸ | HTR2A known ✓ | P28223 | 3/20 | 0.42 |
| ▸ | KDM4A | O75164 | 4/20 | 0.49 |
| ▸ | KDM4B | O94953 | 4/20 | 0.49 |
| ▸ | KDM5C | P41229 | 4/20 | 0.49 |
| ▸ | KDM5B | Q9UGL1 | 4/20 | 0.49 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | HTR7 | P34969 | 4/20 | 0.42 |
| ▸ | HTR6 | P50406 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL9046255 | 1.00 | KDM4A (0.49) | KDM4AKDM4BKDM5CKDM5BSLC6A4 | |
| Oxalic Acid SCHEMBL9049150 | 0.85 | SLC6A4 (0.51) | KDM4AKDM4BKDM5CKDM5BSLC6A4 | |
| SCHEMBL7455861 | 0.84 | SLC6A4 (0.53) | KDM4AKDM4BKDM5CKDM5BSLC6A4 | |
| Oxalic Acid SCHEMBL9048417 | 0.79 | SLC6A4 (0.55) | SLC6A4HTR1ACCR2DRD2HTR7 | |
| Oxalic Acid SCHEMBL9046836 | 0.79 | SLC6A4 (0.51) | SLC6A4HTR1ACCR2DRD2HTR7 | |
| SCHEMBL7459744 | 0.77 | SLC6A4 (0.54) | SLC6A4HTR1ADRD2HTR7HTR6 | |
| Oxalic Acid SCHEMBL9049148 | 0.76 | OPRM1 (0.55) | KDM4AKDM4BKDM5CKDM5BCCR2 | |
| SCHEMBL7465697 | 0.76 | KDM4A (0.41) | KDM4AKDM4BKDM5CKDM5BSLC6A4 | |
| SCHEMBL7463849 | 0.76 | OPRM1 (0.51) | KDM4AKDM4BKDM5CKDM5BSLC6A4 | |
| Oxalic Acid SCHEMBL9046671 | 0.75 | OPRM1 (0.51) | KDM4AKDM4BKDM5CKDM5BCCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125645-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | VALORISATION HSJ LP (CA) | 2026-05-07 | — | — | US | disclosed |
| WO-2024073845-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | VALORISATION HSJ, LIMITED PARTNERSHIP (CA) | 2024-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125645-A1 | METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS | HTR1F, HTR1A, HTR1D | SLC6A4 299/4885HTR1A 2/4885DRD2 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.